Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit You

Showing results (51-60 of 141) with videos related to

Pageof 15
Sort By:
Journal of Gynecologic Oncology|January 12, 2024
Confirmation of the utility of the CA-125 elimination rate (KELIM) as an indicator of the chemosensitivity in advanced-stage ovarian cancer in a "real-life setting"Lilian van Wagensveld, Olivier Colomban, Maaike A van der Aa, et al.
Homeopathy : the Journal of the Faculty of Homeopathy|December 3, 2014
Open-label uncontrolled pilot study to evaluate complementary therapy with Ruta graveolens 9c in patients with advanced cancerGilles Freyer, Benoit You, Stéphanie Villet, et al.
Cancers|December 11, 2019
Are Older Patients with Cervical Cancer Managed Differently to Younger Patients? An International SurveyMaxime Frelaut, Nienke De Glas, Ignacio Zapardiel, et al.
American Journal of Obstetrics and Gynecology|May 21, 2021
Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in FrancePierre Descargues, Touria Hajri, Jérôme Massardier, et al.
Cancer Chemotherapy and Pharmacology|September 23, 2015
Etoposide pharmacokinetics impact the outcomes of lymphoma patients treated with BEAM regimen and ASCT: a multicenter study of the LYmphoma Study Association (LYSA)Benoit You, Gilles Salles, Emmanuel Bachy, et al.
Gynecologic Oncology|June 10, 2020
Transcriptomic and immunohistochemical approaches identify HLA-G as a predictive biomarker of gestational choriocarcinoma resistance to monochemotherapyPierre-Adrien Bolze, Jonathan Lopez, Fabienne Allias, et al.
Bulletin Du Cancer|April 2, 2020
[SARS-CoV-2/COVID 19 Infection and Solid Cancers: Synthesis of Recommendations for Health Professionals]Thomas Grellety, Alain Ravaud, Anne Canivet, et al.
Urology|May 18, 2010
Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumorBenoit You, Ludivine Fronton, Helen Boyle, et al.
Ebiomedicine|February 21, 2023
Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10Olivier Colomban, Elizabeth M Swisher, Rebecca Kristeleit, et al.
The Lancet. Oncology|March 30, 2020
The official French guidelines to protect patients with cancer against SARS-CoV-2 infectionBenoit You, Alain Ravaud, Anne Canivet, et al.
Pageof 15

Showing results (51-60 of 141) with videos related to

Sort By:
Pageof 15
Journal of Gynecologic Oncology|January 12, 2024
Confirmation of the utility of the CA-125 elimination rate (KELIM) as an indicator of the chemosensitivity in advanced-stage ovarian cancer in a "real-life setting"Lilian van Wagensveld, Olivier Colomban, Maaike A van der Aa, et al.
Homeopathy : the Journal of the Faculty of Homeopathy|December 3, 2014
Open-label uncontrolled pilot study to evaluate complementary therapy with Ruta graveolens 9c in patients with advanced cancerGilles Freyer, Benoit You, Stéphanie Villet, et al.
Cancers|December 11, 2019
Are Older Patients with Cervical Cancer Managed Differently to Younger Patients? An International SurveyMaxime Frelaut, Nienke De Glas, Ignacio Zapardiel, et al.
American Journal of Obstetrics and Gynecology|May 21, 2021
Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in FrancePierre Descargues, Touria Hajri, Jérôme Massardier, et al.
Cancer Chemotherapy and Pharmacology|September 23, 2015
Etoposide pharmacokinetics impact the outcomes of lymphoma patients treated with BEAM regimen and ASCT: a multicenter study of the LYmphoma Study Association (LYSA)Benoit You, Gilles Salles, Emmanuel Bachy, et al.
Gynecologic Oncology|June 10, 2020
Transcriptomic and immunohistochemical approaches identify HLA-G as a predictive biomarker of gestational choriocarcinoma resistance to monochemotherapyPierre-Adrien Bolze, Jonathan Lopez, Fabienne Allias, et al.
Bulletin Du Cancer|April 2, 2020
[SARS-CoV-2/COVID 19 Infection and Solid Cancers: Synthesis of Recommendations for Health Professionals]Thomas Grellety, Alain Ravaud, Anne Canivet, et al.
Urology|May 18, 2010
Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumorBenoit You, Ludivine Fronton, Helen Boyle, et al.
Ebiomedicine|February 21, 2023
Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10Olivier Colomban, Elizabeth M Swisher, Rebecca Kristeleit, et al.
The Lancet. Oncology|March 30, 2020
The official French guidelines to protect patients with cancer against SARS-CoV-2 infectionBenoit You, Alain Ravaud, Anne Canivet, et al.
Pageof 15